Abstract

The transition from naive to primed pluripotency is accompanied by an extensive reorganisation of transcriptional and epigenetic programmes. However, the role of transcriptional enhancers and three-dimensional chromatin organisation in coordinating these developmental programmes remains incompletely understood. Here, we generate a high-resolution atlas of gene regulatory interactions, chromatin profiles and transcription factor occupancy in naive and primed human pluripotent stem cells, and develop a network-graph approach to examine the atlas at multiple spatial scales. We uncover highly connected promoter hubs that change substantially in interaction frequency and in transcriptional co-regulation between pluripotent states. Small hubs frequently merge to form larger networks in primed cells, often linked by newly-formed Polycomb-associated interactions. We identify widespread state-specific differences in enhancer activity and interactivity that correspond with an extensive reconfiguration of OCT4, SOX2 and NANOG binding and target gene expression. These findings provide multilayered insights into the chromatin-based gene regulatory control of human pluripotent states.

The role of transcriptional enhancers and 3D chromatin organisation in coordinating the transition from naive to primed pluripotency remains poorly understood. Here the authors generate a high-resolution atlas of gene regulatory interactions, chromatin profiles and transcription factor occupancy in naive and primed human pluripotent stem cells to provide insights into these developmental processes.

Details

Title
Widespread reorganisation of pluripotent factor binding and gene regulatory interactions between human pluripotent states
Author
Chovanec, Peter 1 ; Collier, Amanda J 2   VIAFID ORCID Logo  ; Krueger, Christel 2   VIAFID ORCID Logo  ; Várnai Csilla 3   VIAFID ORCID Logo  ; Semprich, Claudia I 2   VIAFID ORCID Logo  ; Schoenfelder, Stefan 4   VIAFID ORCID Logo  ; Corcoran, Anne E 1   VIAFID ORCID Logo  ; Rugg-Gunn, Peter J 5   VIAFID ORCID Logo 

 Babraham Institute, Lymphocyte Signalling and Development Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); Babraham Institute, Nuclear Dynamics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777) 
 Babraham Institute, Epigenetics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777) 
 Babraham Institute, Nuclear Dynamics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); University of Birmingham, Centre for Computational Biology, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486) 
 Babraham Institute, Nuclear Dynamics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); Babraham Institute, Epigenetics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777) 
 Babraham Institute, Epigenetics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); Wellcome – MRC Cambridge Stem Cell Institute, Cambridge, UK (GRID:grid.449973.4) (ISNI:0000 0004 0612 0791) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2509427651
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.